Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates

Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates

Record Revenue: Net revenues of $26.6 million in Q2 2025, a 35% increase compared to $19.7 million in Q2 2024, driven by national brand growth and product innovation.Record Profitability: Gross profit before fair value adjustments rose 52% to $10.8 million…

Sosiak Explains Cannara's Q2 2025 Results

In our latest Trade To Black podcast for April 28, 2025, host Shadd Dales and Anthony Varrell break down the latest developments in the cannabis industry and updates on SAFE Banking progress. Cannara Biotech’s CFO Nick Sosiak shares details on their record Q2 2025 earnings, and Michael Bronstein, President of the American Trade Association for Cannabis and Hemp, joins us to discuss Texas hemp industry developments, adult-use cannabis progress in…

Q2 2025 marks another record quarter for Cannara Biotech

Cannara Biotech brought in $36.8 million in gross revenue in the three months ended February 28, 2025 (Q2 2025), $26.6 million in net revenue, and... The post Q2 2025 marks another record quarter for Cannara Biotech appeared first on StratCann.